Clinical Trials Browser

Phase 1/2 × Completed × OTHER × Clear all

NCT02866747 2026-04-14

STERIMGLI

Phase 1/2 Completed

Glioblastoma

NCT07529613 2026-04-14

T-DXd_HER2Low

Phase 1/2 Completed

Gastrointestinal

Stomach Neoplasms

NCT01241734 2026-04-08

RICER

Phase 1/2 Completed

18 enrolled 15 charts

Lymphoma, Large B-Cell, Diffuse

NCT04037254 2026-04-06

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

Phase 1/2 Completed

22 enrolled 13 charts

Prostatic Neoplasms

NCT01502085 2026-04-03

RZD

Phase 1/2 Completed

25 enrolled 5 charts

Multiple Myeloma

NCT02204085 2026-04-03

A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1/2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01242267 2026-04-02

Thal/Mel/Vel

Phase 1/2 Completed

29 enrolled 13 charts

Multiple Myeloma

NCT03370276 2026-04-02

Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Phase 1/2 Completed

95 enrolled 15 charts

Squamous Cell Carcinoma of Head and Neck, Neoplasms, Squamous Cell

NCT07505615 2026-04-01

VG-INFUSE Tria

Phase 1/2 Completed

Non-Muscle Invasive Bladder Neoplasms

NCT04801147 2026-03-27

DENDR1

Phase 1/2 Completed

Glioblastoma

NCT00576979 2026-03-24

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Phase 1/2 Completed

51 enrolled 16 charts

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05046171 2026-03-24

Decreasing Polypharmacy in Older Adults With Curable Cancers Trial

Phase 1/2 Completed

Neoplasms

NCT03709446 2026-03-19

Leflunomide in Previously Treated Metastatic Triple Negative Cancers

Phase 1/2 Completed

Breast Diseases, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03441958 2026-03-18

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

Phase 1/2 Completed

Multiple Myeloma

NCT02386397 2026-03-12

BREGO

Phase 1/2 Completed

Gastrointestinal

Gastrointestinal Neoplasms

NCT03223779 2026-03-12

Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT02213913 2026-03-11

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Phase 1/2 Completed

55 enrolled 17 charts

LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Intraocular Lymphoma

NCT02779855 2026-03-10

Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Phase 1/2 Completed

50 enrolled 12 charts

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Ductal, Triple Negative Breast Neoplasms

NCT05494580 2026-03-10

Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer

Phase 1/2 Completed

Ovarian Neoplasms

NCT00797719 2026-03-05

Short Neoadjuvant Hemithoracic IMRT for MPM

Phase 1/2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT03602833 2026-03-02

Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma

Phase 1/2 Completed

12 enrolled 9 charts

Sarcoma

NCT03828799 2026-02-27

FOLFIRINOX-R

Phase 1/2 Completed

13 enrolled 22 charts

Gastrointestinal

Colorectal Neoplasms

NCT03786237 2026-02-24

Rigosertib for RDEB-SCC

Phase 1/2 Completed

Carcinoma, Squamous Cell, Epidermolysis Bullosa Dystrophica

NCT01203722 2026-02-19

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

Phase 1/2 Completed

87 enrolled 24 charts

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Lymphoma, Hematologic Neoplasms

NCT02523469 2026-02-17

ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer

Phase 1/2 Completed

67 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT06661902 2026-02-17

BURN

Phase 1/2 Completed

Prostatic Neoplasms

NCT01543659 2026-02-13

Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms

NCT03123276 2026-02-13

GEMMK

Phase 1/2 Completed

25 enrolled 15 charts

Sarcoma

NCT03785873 2026-02-13

Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer

Phase 1/2 Completed

34 enrolled 13 charts

Gastrointestinal

Biliary Tract Neoplasms

NCT03529448 2026-02-12

GEINOCANN

Phase 1/2 Completed

Glioblastoma

NCT01517451 2026-02-11

Radiation and Androgen Ablation for Prostate Cancer

Phase 1/2 Completed

45 enrolled 11 charts

Adenocarcinoma of the Prostate

NCT00458536 2026-02-09

Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF

Phase 1/2 Completed

38 enrolled 3 charts

Kidney Neoplasms

NCT02520063 2026-02-06

Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer

Phase 1/2 Completed

15 enrolled 18 charts

Breast Neoplasms

NCT05499663 2026-02-06

POSTHOC

Phase 1/2 Completed

51 enrolled 15 charts

Motor Activity, Neoplasms, Signs and Symptoms

NCT00989469 2026-02-05

NEXIRI

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT03211416 2026-02-05

Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer

Phase 1/2 Completed

37 enrolled 13 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT00625755 2026-01-23

A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma

Phase 1/2 Completed

Carcinoma, Renal Cell

NCT00626860 2026-01-23

The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma

Phase 1/2 Completed

Melanoma

NCT03003468 2026-01-20

Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017

Phase 1/2 Completed

35 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT03575793 2026-01-20

A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer

Phase 1/2 Completed

39 enrolled 18 charts

Lung Neoplasms

NCT04139057 2026-01-20

EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC

Phase 1/2 Completed

Squamous Cell Carcinoma of Head and Neck

NCT04509726 2026-01-20

EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal Carcinoma

Phase 1/2 Completed

Nasopharyngeal Carcinoma

NCT04627740 2026-01-20

Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT06553157 2026-01-20

Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

Phase 1/2 Completed

Ototoxicity

NCT06556108 2026-01-20

ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT02805725 2026-01-14

TARMIC

Phase 1/2 Completed

50 enrolled 15 charts

Sarcoma

NCT05276284 2026-01-14

TEMPLE

Phase 1/2 Completed

Neoplasm Metastasis

NCT03993678 2025-12-30

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.

Phase 1/2 Completed

DermatologicSarcoma

Melanoma, Sarcoma

NCT06562673 2025-12-29

IACE-OS

Phase 1/2 Completed

Bone Neoplasms, Osteosarcoma

NCT01665794 2025-12-22

Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Completed

Multiple Myeloma